Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SBC Medical Group Holdings (SBCWW) Shares Outstanding (Diluted Average) (2023 - 2025)

Historic Shares Outstanding (Diluted Average) for SBC Medical Group Holdings (SBCWW) over the last 3 years, with Q3 2025 value amounting to $103.1 million.

  • SBC Medical Group Holdings' Shares Outstanding (Diluted Average) rose 845.96% to $103.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $103.1 million, marking a year-over-year increase of 845.96%. This contributed to the annual value of $96.6 million for FY2024, which is 251.46% up from last year.
  • SBC Medical Group Holdings' Shares Outstanding (Diluted Average) amounted to $103.1 million in Q3 2025, which was up 845.96% from $103.5 million recorded in Q2 2025.
  • In the past 5 years, SBC Medical Group Holdings' Shares Outstanding (Diluted Average) ranged from a high of $103.5 million in Q2 2025 and a low of $8.6 million during Q2 2023
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $94.2 million (2023), whereas its average is $81.7 million.
  • The largest annual percentage gain for SBC Medical Group Holdings' Shares Outstanding (Diluted Average) in the last 5 years was 99248.16% (2024), contrasted with its biggest fall of 95.84% (2024).
  • SBC Medical Group Holdings' Shares Outstanding (Diluted Average) (Quarter) stood at $94.2 million in 2023, then grew by 2.51% to $96.6 million in 2024, then grew by 6.81% to $103.1 million in 2025.
  • Its last three reported values are $103.1 million in Q3 2025, $103.5 million for Q2 2025, and $103.3 million during Q1 2025.